• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

High-flying Hologic splits stock

Article

Bone densitometry firm Hologic of Waltham, MA, announced a two-for-onestock split effective March 25. Hologic's share price has risensteadily since last year, when Merck received marketing approvalfor its Fosamax osteoporosis drug, and the split will

Bone densitometry firm Hologic of Waltham, MA, announced a two-for-one

stock split effective March 25. Hologic's share price has risen

steadily since last year, when Merck received marketing approval

for its Fosamax osteoporosis drug, and the split will make the

company's stock more affordable. Hologic's stock was trading at

around $50 a share the week before the split. It had been trading

at around $14 a share last March (SCAN 12/27/95).

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.